Pass codes, phone numbers and addresses. We all have a lot of numbers in our heads, but heart experts at The Ohio State University Wexner Medical Center say there are 5 more you need to know to help keep your heart healthy.
Mount Sinai researchers generated their engineered cardiac tissue from human embryonic stem cells with the resulting muscle having remarkable similarities to native heart muscle, including the ability to beat and contract like the human heart. This research breakthrough study was highlighted as the cover story of the February 2014 issue of The FASEB Journal.
A strong sensation of pressure—what some have described as an elephant sitting on one’s chest—can be one of the red flags that someone is experiencing a heart attack and should seek immediate medical assistance. But if you are a woman, waiting to feel this type of pain may be a mistake. Fifty percent of the time a woman has a heart attack, there will be no chest pain involved, explains Dr. Liliana Cohen, a board-certified cardiologist with Rutgers Robert Wood Johnson Medical Group.
Heart transplantation continues to be the “gold standard” treatment for end-stage heart failure, and a large number of patients now live 20 years or more after surgery
Detailed prediction models that project long-term patient mortality following PCI and CABG surgery can be useful for the heart team when determining the best treatment strategy for individual patients
February is American Heart Month. “Top 10 Things Women Need to Do to Protect their Hearts,” from cardiovascular disease by leading female cardiovascular experts of Mount Sinai Heart at The Mount Sinai Hospital.
A new device tested first at the University of Michigan may provide a minimally invasive option for the elderly who are facing life-threatening thoracic aneurysms.
Like many active women, Ellen Abramson never gave much thought to her risk of heart disease—until the day she suddenly found herself having a heart attack. Ellen shares her experience as survivor of cardiac arrest in the February issue of Heart Insight, a quarterly magazine for patients, their families and caregivers. Heart Insight is published by the American Heart Association (AHA) and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
A UCLA team has developed an easy-to-use "risk calculator" that helps predict heart failure patients' chances of survival for up to five years and can assist doctors in determining whether more or less aggressive treatment is appropriate.
Kira Taylor, Ph.D., M.S., assistant professor, University of Louisville School of Public Health and Information Sciences, and her research team have identified five new genes associated with increased waist-to-hip ratio, potentially moving science a step closer to developing a medication to treat obesity or obesity-related diseases.
Older women who spend a majority of their day sitting or lying down are at increased risk for cardiovascular disease, coronary heart disease, cancer and death, finds a new study from the American Journal of Preventive Medicine.
New report in Nature Communications by Icahn School of Medicine at Mount Sinai shows their new statin nanotherapy can target high-risk inflammation inside heart arteries that causes heart attacks or stroke.
A study conducted by researchers from several institutions, including the Perelman School of Medicine at the University of Pennsylvania, has found similarly low rates of complication and death among U.S. patients who are treated with the three most common systems for placing stents in blocked carotid arteries of the neck.
The immune system plays an important role in the heart’s response to injury. Now, researchers at Washington University School of Medicine in St. Louis have shown that two major pools of immune cells are at work in the heart. Both belong to a class of cells known as macrophages. One appears to promote healing, while the other likely drives inflammation, which is detrimental to long-term heart function.
Researchers at Wayne State University have discovered a potential way to improve the lipid profiles in patients undergoing hemodialysis that may prevent cardiovascular disease common in these patients. Patients undergoing hemodialysis for kidney failure are at a greater risk for atherosclerosis, a common disease in which plaque builds up inside the arteries. Atherosclerosis can lead to serious problems including heart attack, stroke or even death.
Minority of panel members who disagree with raising systolic blood pressure targets for people over 60 years of age provide their evidence in a new commentary in the Annals of Internal Medicine.
A study led by researchers at the University of California, San Diego School of Medicine shows that one of the most widely used systems for predicting risk of adverse heart events should be re-evaluated. A surprise finding was that coronary artery calcium (CAC) density may be protective against cardiovascular events. The study of CAC will be published in the January 15 issue of the Journal of the American Medical Association.
Cedars-Sinai Heart Institute researchers have found that six proteins – five more than previously thought – are responsible for cell-to-cell communication that regulates the heart and plays a role in limiting the size of heart attacks and strokes. The smallest of these proteins directs the largest in performing its role of coordinating billions of heart cells during each heartbeat. Together, the proteins synchronize the beating heart, the researchers determined.
An international research team led by Mount Sinai Heart at Icahn School of Medicine at Mount Sinai, is testing its novel sugar-based tracer contrast agent to be used with positron emission tomography (PET) imaging to help in the hunt for dangerous inflammation and high-risk vulnerable atherosclerotic plaque inside vessel walls that causes acute heart attacks and strokes.
A new MRI method to map creatine at higher resolutions in the heart may help clinicians and scientists find abnormalities and disorders earlier than traditional diagnostic methods, researchers at the Perelman School of Medicine at the University of Pennsylvania suggest in a new study published online today in Nature Medicine.
A new “fluid biopsy” technique that could identify patients at high risk of a heart attack by identifying specific cells as markers in the bloodstream has been developed by a group of researchers at The Scripps Research Institute.
Red blood cells are the body’s true shape shifters, perhaps the most malleable of all cell types. While studying how blood clots contract, researchers discovered a new geometry that red blood cells assume, when compressed during clot formation.
T2 Bio and collaborators published data in Blood describing novel clot structure biology detected while testing T2 Bio’s T2HemoStat™ that could help identify stroke and heart attack victims who are less responsive to medications.
Current protocols for matching donor hearts to recipients foster sex mismatching and heart size disparities, according to a first-of-its kind analysis by physicians at the University of Maryland School of Medicine. Matching by donor heart size may provide better outcomes for recipients.
Doctors may need to treat high blood pressure in women earlier and more aggressively than they do in men, according to scientists at Wake Forest Baptist Medical Center.
A new study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent role in helping determine a person’s risk for heart attack and heart disease-related death, as well as the need for angioplasty or bypass surgery. CAC screening provides a direct measure of calcium deposits in heart arteries and is easily obtained on a computed tomography (CT) scan.
Wayne State University and Health Enhancement Products, Inc. (OTC.BB:HEPI.OB – News), announces the publication of a scientific article in the Journal of Nutrition & Metabolism, “ProAlgaZyme sub-fraction improves the lipoprotein profile of hypercholesterolemic hamsters, while inhibiting production of betaine, carnitine, and choline metabolites.”
Atrial fibrillation, long considered the most common condition leading to an irregular heartbeat, is a growing and serious global health problem, according to the first study ever to estimate the condition’s worldwide prevalence, death rates and societal costs. The World Health Organization data analysis shows that 33.5 million people worldwide – or .5% of the world’s population – have the condition.
A UCLA research team has found no evidence of an association between iron levels in the body and the risk of atherosclerosis, the hardening and narrowing of the arteries that leads to cardiovascular disease, the No. 1 killer in the U.S. The discovery, based on a comprehensive study in a mouse model of atherosclerosis, contradicts a long-held hypothesis about the role of iron in the disease and carries important implications for patients with chronic kidney disease or anemia related to inflammatory disorders, many of whom receive high-dose iron supplementation therapy.
Gurusher Panjrath, M.D., assistant professor of medicine and director of the Heart Failure and Mechanical Support Program at the George Washington University School of Medicine and Health Sciences, was recently published in the journal Science Translational Medicine for his study, "Metabolic Rates of ATP Transfer Through Creatine Kinase (CK Flux) Predict Clinical Heart Failure Events and Death."
For patients at risk for sudden cardiac arrest, a new defibrillator is like the standby ambulance and medical team they need when their hearts abruptly stop. Treatment within minutes is the critical difference between life and death. Orlando Health Heart Institute is the first in Florida to offer the advanced technology designed for patients unable to receive a traditional defibrillator. Pavel Guguchev, MD, and Roland Filart, MD, implanted the first device in the state on December 3.
Johns Hopkins researchers have identified a new way to predict which heart failure patients are likely to see their condition get worse and which ones have a better prognosis. Their study is one of the first to show that energy metabolism within the heart, measured using a noninvasive magnetic resonance imaging (MRI) test, is a significant predictor of clinical outcomes, independent of a patient’s symptoms or the strength of the heart’s ability to pump blood, known as the ejection fraction.
For patients with stable coronary artery disease (CAD) who are not experiencing a heart attack and an abnormal stress test, treatment of their narrowed arteries by the common procedure of angioplasty may not provide additional benefits compared to drug therapy alone. This finding results from a survey of more than 4,000 patients with myocardial ischemia, or inadequate circulation, led by cardiologists at Stony Brook University School of Medicine. The survey results are published in the online first edition of JAMA Internal Medicine.
• Among a group of veterans discharged from the hospital after acute kidney injury or heart attacks, death occurred most often in patients who experienced both conditions and least often in patients experiencing heart attacks alone.
• Patients with acute kidney injury later experienced more major heart and kidney problems than those who had heart attacks.
A national group of leading scientists, including one University of Alabama at Birmingham expert, says fewer people are dying of stroke, but the mechanisms remain unknown.
For many households of Mexican descent in the United States, the days following Thanksgiving aren’t only about wrapping gifts but also about wrapping tamales.
Leading cardiologists at The Mount Sinai Hospital have contributed to the development of a new classification system called MOGE(S) for cardiomyopathies, the diseases of the heart muscle which can lead to heart enlargement and heart failure.
A byproduct of cholesterol functions like the hormone estrogen to fuel the growth and spread of the most common types of breast cancers, researchers at the Duke Cancer Institute report.
Johns Hopkins heart researchers are unraveling the mystery of how a modified pacemaker used to treat many patients with heart failure, known as cardiac resynchronization therapy (CRT), is able to strengthen the heart muscle while making it beat in a coordinated fashion. In a new study conducted on animal heart cells described in the Journal of Clinical Investigation, the scientists show that CRT changes these cells so they can contract more forcefully. The researchers also identified an enzyme that mimics this effect of CRT without use of the device.
Results of a Johns Hopkins-led study have identified a possible link between a history of sudden drops in blood pressure and the most common form of irregular heartbeat.
Older men whose testosterone levels were neither low nor high tended to live longer, according to new research accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Dallas, TX – Researchers from the Sinai Center for Thrombosis Research presented findings from a Phase 2a trial substudy that examined the antiplatelet effects of CSL112, a novel apolipoprotein A-I (apo A-I) infusion therapy, at the American Heart Association 2013 Scientific Sessions.